Purpose: Inferior attenuation is a common problem in the interpretation of myocardial perfusion SPECT. We explored whether cardiovascular magnetic resonance (CMR) was a useful adjunct in differentiating between artifactual attenuation of the inferior wall and the presence of myocardial infarction and/or ischemia.
Methods: We used CMR to assess resting wall motion, myocardial perfusion, and the presence of infarction with late gadolinium enhancement in 30 patients with presumed inferior attenuation on ungated myocardial perfusion SPECT, but where uncertainty was present over interpretation of the inferior wall. Perfusion CMR was analyzed visually and quantitatively.
Results: In 23 patients (77%), CMR excluded infarction or ischemia in the inferior wall. The myocardial perfusion reserve index (MPR1) was the same in the inferior and remote myocardium (1.74 +/- 0.43 vs. 1.77 +/- 0.50, p = 0.61). Coronary angiography was performed in 11 of these patients, and was normal in all cases. In the remaining seven subjects (23%), significant abnormality was detected by CMR (infarction, 5; wall motion abnormality, 3; perfusion defect, 5). In these patients, the MPR1 was reduced in the inferior myocardium compared with remote (1.07 +/- 0.19 vs. 1.74 +/- 0.49, p = 0.04). Coronary angiography was performed in three of these patients, revealing significant coronary disease in the artery supplying the inferior territory in all patients.
Conclusion: Approximately one-quarter of patients with inferior attenuation on ungated, nonattenuation corrected myocardial perfusion SPECT have abnormalities on CMR. CMR can readily distinguish between artifact, ischemia, and infarction in these cases and in some cases might obviate the need for diagnostic coronary angiography.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1081/jcmr-200053627 | DOI Listing |
The article presents a clinical case of secondary cardiomyopathy in an HIV patient with plasmablastic lymphoma due to the combined pathology (HIV infection with ongoing antiretroviral therapy in combination with antitumor therapy), in which the use of multimodal imaging contributed to establishing the correct diagnosis and excluding the unjustified use of invasive methods for diagnosing ischemic heart disease.
View Article and Find Full Text PDFDiscov Med (Cham)
January 2025
Institute of Biomedical Engineering, University of Toronto, Toronto, ON Canada.
Background: Microvascular dysfunction (MVD) is a recognized sign of disease in heart failure progression. Intact blood vessels exhibit abnormal vasoreactivity in early stage, subsequently deteriorating to rarefaction and reduced perfusion. In managing heart failure with preserved ejection fraction (HFpEF), earlier diagnosis is key to improving management.
View Article and Find Full Text PDFJTCVS Open
December 2024
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
Objective: To develop a model for preoperatively predicting postcardiotomy cardiogenic shock (PCCS) in patients with poor left ventricular (LV) function undergoing cardiac surgery.
Methods: From the Society of Thoracic Surgeons Adult Cardiac Database, 11,493 patients with LV ejection fraction ≤35% underwent isolated on-pump surgery from 2018 through 2019, of whom 3428 experienced PCCS. In total, 68 preoperative clinical variables were considered in machine-learning algorithms trained and optimized using scikit-learn software.
Cardiovasc Res
January 2025
State Key Laboratory of Cardiovascular Disease, Clinical Pharmacology Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Aims: The therapeutic efficacy of coronary revascularization is compromised by myocardial ischemia-reperfusion (MI/R) injury. Higher levels of circulating arachidonic acid (AA) are reportedly associated with lower risk of cardiovascular disease. The cyclooxygenase (COX) pathway metabolizes AA into prostaglandins (PGs) and the platelet-activating thromboxane A2 (TXA2), which is inhibited by aspirin.
View Article and Find Full Text PDFNucl Med Commun
January 2025
Department of Radiological Sciences, Oncology and Anatomical Pathology, Nuclear Medicine Unit, 'Sapienza' University, Rome.
Purpose: Coronary artery disease (CAD) underestimation represents a major pitfall of single-photon emission computed tomography-myocardial perfusion imaging (SPECT-MPI). Coronary artery calcium score (CACS) has emerged as a sensitive tool for the assessment of suspect CAD; however, the integration of SPECT-MPI with CACS has been seldom evaluated, so far, and was therefore the aim of the present study.
Methods: Patients undergoing SPECT-MPI with CACS and subsequent coronary angiography were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!